Plasma Fractionation Market size was valued at USD 27.1 billion in 2022 and is expected to reach USD 43.52 billion By 2030 and grow at a CAGR of 6.1% over the forecast period of 2023-2030.

The plasma fractionation market is a rapidly growing sector in the healthcare industry, driven by the increasing demand for plasma-derived products. Plasma fractionation involves the separation of plasma into its various components, such as albumin, immunoglobulins, clotting factors, and others. These components are then used to develop life-saving therapies for patients with rare and chronic diseases.

One of the key factors contributing to the growth of the plasma fractionation market is the rising prevalence of immune system disorders and bleeding disorders. Conditions like primary immunodeficiency diseases (PIDD), hemophilia, and von Willebrand disease require regular infusion of plasma-derived products to manage symptoms and improve quality of life. As a result, there is a growing need for reliable and safe sources of these products.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2992

Moreover, advancements in technology have significantly improved the efficiency and safety of plasma fractionation processes. The introduction of advanced filtration techniques, chromatography systems, and viral inactivation methods has enhanced product purity while minimizing the risk of transmitting infectious agents These advancements have not only increased the availability of plasma-derived products but have also provided patients with a greater sense of security and peace of mind.

KEY MARKET SEGMENTS

By Product

• Albumin
• Von Willebrand Factor
• PCC

By Application

• Neurology
• Immunology
• Hematology
• Rheumatology

By End User

• Hospitals
• Clinics
• Clinical Research

Major Players Listed in the Report are as Follows:

Bio Products Laboratory (BPL), Biotest AG, China Biologic Products Holdings, Inc., CSL Limited, Japan Blood Products Organisation, Kedrion S.p.A., LFB Group, Octapharma AG, Sanquin, Shanghai RAAS. And the final reports list additional participants.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)